Arthritis / Rheumatology News From Medical News TodayLatest Arthritis / Rheumatology News From Medical News Today.FDA Advisory Committee Recommends Approval Of Actemra For The Treatment Of Rheumatoid Arthritis- July 31, 2008 Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of Actemra (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody, for reducing the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).http://www.medicalnewstoday.com/articles/116674.php Frankincense Provides Relief To Arthritis Sufferers- July 31, 2008 An enriched extract of the 'Indian Frankincense' herb Boswellia serrata has been proven to reduce the symptoms of osteoarthritis. Research published in BioMed Central's open access journal Arthritis Research & Therapy has shown that patients taking the herbal remedy showed significant improvement in as little as seven days.http://www.medicalnewstoday.com/articles/116654.php FDA Advisory Committee Recommends Approval Of ACTEMRA(R) (tocilizumab) For The Treatment Of Rheumatoid Arthritis- July 30, 2008 Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of ACTEMRA(R) (tocilizumab), a novel interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody, for reducing the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).http://www.medicalnewstoday.com/articles/116548.php Idea AG Withdraws Its Marketing Authorisation Application For Diractin(ketoprofen), Europe- July 28, 2008 The European Medicines Agency (EMEA) has been formally notified by Idea AG of its decision to withdraw its application for a centralized marketing authorisation for the medicine Diractin (ketoprofen) 22.9 mg gel. Diractin was expected to be used for the symptomatic treatment of inflammation and pain in osteoarthritis. The application for the marketing authorisation for Diractin was submitted to the EMEA on 23 May 2007.http://www.medicalnewstoday.com/articles/116333.php No Justification For Denying Obese Patients Knee Replacements- July 28, 2008 There is no justification for denying obese patients knee replacement surgery: They benefit almost as much as anyone else from the procedure, concludes a small study published ahead of print in the Annals of the Rheumatic Diseases. Around 55,000 knee replacements are performed every year in England to relieve the pain and disability of knee osteoarthritis.http://www.medicalnewstoday.com/articles/116294.php Cartilage Repair Gel Under Development, Which Will Improve Quality Of Life For People Suffering With Medical Joint Trouble- July 24, 2008 The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin-out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis.http://www.medicalnewstoday.com/articles/115928.php New Guidelines For Treating Rheumatoid Arthritis- July 23, 2008 Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB). Lead author Kenneth Saag, M.D., M.Sc.http://www.medicalnewstoday.com/articles/115869.php Roche Comment On NICE Anti-TNF Inhibitor Sequencing FAD- July 23, 2008 Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab), following the use of one anti-TNF, for this debilitating disease.http://www.medicalnewstoday.com/articles/115813.php Could Arthritis Wonder Drugs Provide Clues For All Disease- July 20, 2008 Drugs that have helped treat millions of rheumatoid arthritis sufferers may hold the key to many more medical conditions, including atherosclerosis - a leading cause of heart disease - says the researcher who jointly invented and developed them.http://www.medicalnewstoday.com/articles/115500.php Study Showed Half Of Patients Treated With Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission- July 20, 2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate and ETanercept in Active Early Rheumatoid Arthritis) trial demonstrating that half of patients treated with the combination of ENBREL and methotrexate achieved Disease Activity Score (DAS) clinical remission and nearly all had no progression of joint damage.http://www.medicalnewstoday.com/articles/115549.php |